| Hearts and Minds Investments Limited (HM1) ORDINARY FULLY PAID |
Financials |
$689 |
Weekly NTA Estimate
|
25 Aug 2025 9:22AM |
$3.310 |
$3.010 |
fallen by
9.06%
|
|
| Tasmea Limited (TEA) ORDINARY FULLY PAID |
Industrials |
$2,543 |
Tasmea Limited - FY25 Results Presentation
|
25 Aug 2025 9:22AM |
$4.240 |
$9.200 |
risen by
116.98%
|
|
TEA - Price-sensitive ASX Announcement
Full Release
Key Points
- Tasmea Limited achieved strong revenue, EBITDA, and NPATA growth in FY25.
- The company operates a group of technical engineering and asset management businesses.
- Key service sectors include mining, energy, resources, and infrastructure.
- Growth is driven by a combination of organic development and strategic acquisitions.
- Tasmea has a robust pipeline of opportunities and is focused on expanding service offerings.
- The company maintains prudent financial management and a disciplined approach to capital allocation.
- Operational excellence, safety, and client satisfaction are central to Tasmea's strategy.
- Tasmea is committed to delivering sustainable shareholder value and pursuing further expansion opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Botanix Pharmaceuticals Ltd (BOT) ORDINARY FULLY PAID |
Health Care |
$60 |
Botanix Appoints Dr Patricia Walker to the Board
|
25 Aug 2025 9:21AM |
$0.150 |
$0.022 |
fallen by
85.33%
|
|
| Basin Energy Limited (BSN) ORDINARY FULLY PAID |
Energy |
$7 |
Trading Halt
|
25 Aug 2025 9:21AM |
$0.025 |
$0.030 |
risen by
20%
|
|
BSN - Price-sensitive ASX Announcement
Full Release
Key Points
- Basin Energy Limited (ASX: BSN) requested a trading halt on 13 June 2024.
- The trading halt is due to an impending announcement regarding a capital raising.
- Trading in BSN securities is halted until 17 June 2024 or until the announcement is released.
- The halt is intended to ensure the market is fully informed.
- Announcement issued by the company secretary, Zakir Hood.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Diatreme Resources Limited (DRX) ORDINARY FULLY PAID |
Materials |
$65 |
Project Status Granted, Key Tenure Renewals Secured
|
25 Aug 2025 9:20AM |
$0.019 |
$0.013 |
fallen by
31.58%
|
|
DRX - Price-sensitive ASX Announcement
Full Release
Key Points
- Key tenure renewals granted for Cape Bedford and Cape Flattery silica sand projects.
- Renewals are critical for ongoing exploration and development activities.
- Renewals provide project certainty and continuity for Diatreme Resources Limited.
- Engagement with Traditional Owners and regulatory authorities highlighted.
- Renewals support the company's focus on advancing project approvals and development milestones.
- Company aims to maximize shareholder value through continued project progression.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,418 |
Weekly Estimated NTA as at 22 August 2025
|
25 Aug 2025 9:20AM |
$7.350 |
$6.860 |
fallen by
6.67%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$6 |
Agreement Expanded with Axiom Group to Secure USA REE Assets
|
25 Aug 2025 9:20AM |
$0.029 |
$0.041 |
risen by
41.38%
|
|
| Aussie Broadband Limited (ABB) ORDINARY FULLY PAID |
Communication Services |
$1,565 |
Application for quotation of securities - ABB
|
25 Aug 2025 9:19AM |
$4.460 |
$4.960 |
risen by
11.21%
|
|
| Capral Limited (CAA) ORDINARY FULLY PAID |
Materials |
$182 |
Completion of Comsupply acquisition
|
25 Aug 2025 9:19AM |
$11.050 |
$11.510 |
risen by
4.16%
|
|
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$747 |
Weekly Estimate NTA for 22.08.2025
|
25 Aug 2025 9:18AM |
$3.010 |
$3.590 |
risen by
19.27%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$13 |
FY25 Appendix 4G and Corporate Governance Statement
|
25 Aug 2025 9:18AM |
$0.295 |
$0.058 |
fallen by
80.34%
|
|
| Pengana International Equities Limited (PIA) ORDINARY FULLY PAID |
Financials |
$290 |
Update - Notification of buy-back - PIA
|
25 Aug 2025 9:17AM |
$1.265 |
$1.125 |
fallen by
11.07%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$13 |
FY25 Market Update
|
25 Aug 2025 9:17AM |
$0.295 |
$0.058 |
fallen by
80.34%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- GSS released an FY25 Market Update on 28 June 2024.
- The company’s strategic focus is on expanding international market adoption, particularly in the USA and Europe.
- Key growth drivers include new product launches and ongoing regulatory submissions.
- Priority is given to expanding use of the EasyScreen and 3base molecular detection platform.
- Distribution agreements and partnerships are highlighted as important for market penetration.
- GSS continues to invest in research and development, with ongoing clinical trials.
- Financial update notes prudent cost management and projected improvements in gross margins.
- The company reports having sufficient cash reserves to fund its growth plans.
- Confidence is expressed in achieving sustainable revenue growth and further clinical validation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$348 |
Corporate Governance Statement
|
25 Aug 2025 9:15AM |
$0.685 |
$0.645 |
fallen by
5.84%
|
|
| Santos Limited (STO) ORDINARY FULLY PAID |
Energy |
$26,080 |
XRG Consortium Indicative Proposal Update
|
25 Aug 2025 9:15AM |
$7.760 |
$8.030 |
risen by
3.48%
|
|
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$348 |
Tax components of the distribution
|
25 Aug 2025 9:15AM |
$0.685 |
$0.645 |
fallen by
5.84%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$13 |
FY25 Results Release
|
25 Aug 2025 9:15AM |
$0.295 |
$0.058 |
fallen by
80.34%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited announces the timing of FY25 financial results.
- Audited FY25 results will be released by the end of August 2024.
- The announcement is made in compliance with listing rules and reporting obligations.
- No unforeseen events have impacted the timing of the results release.
- Company operations are continuing as usual.
- The update is procedural and intended for investors and stakeholders.
- Announcement is signed by the Company Secretary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVT Limited (EVT) ORDINARY FULLY PAID |
Communication Services |
$2,295 |
Year End Results Announcement
|
25 Aug 2025 9:15AM |
$17.140 |
$14.120 |
fallen by
17.62%
|
|
EVT - Price-sensitive ASX Announcement
Full Release
Key Points
- EVT Limited announced full year earnings growth driven by a stronger second half.
- Normalised Revenue increased to $1,236.9 million, up 1.3%.
- Normalised EBITDA rose to $160.8 million, up 6.3%.
- Normalised Profit After Tax climbed to $38.4 million, up 12.7%.
- Reported Net Profit After Tax escalated by 593.4% to $33.4 million.
- Total Dividend for the year was 38 cents per share.
- Hotels division achieved record revenue and EBITDA results despite challenging conditions.
- Entertainment division saw a recovery in the fourth quarter with strategic upgrades to locations.
- Thredbo experienced revenue growth despite poor winter weather conditions.
- Property division engaged in strategic divestments and developments, maintaining the portfolio value.
- EVT Connect Hospitality launched to expand hotel management solutions.
- Positive outlook for FY26 with expected EBITDA growth contingent on film and weather conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EVT Limited (EVT) ORDINARY FULLY PAID |
Communication Services |
$2,295 |
Year End Results Announcement
|
25 Aug 2025 9:15AM |
$17.140 |
$14.120 |
fallen by
17.62%
|
|
EVT - Price-sensitive ASX Announcement
Full Release
Key Points
- Full year earnings growth driven by a stronger second half.
- Normalised Revenue: $1,236.9 million, up 1.3%.
- Normalised EBITDA: $160.8 million, up 6.3%.
- Reported Net Profit After Tax: $33.4 million, up 593.4%.
- Final Dividend: 22 cents per share, total for the year: 38 cents.
- Hotel division achieved record results despite challenges.
- Entertainment division impacted by Hollywood strikes, recovery in Q4.
- Thredbo revenue up despite adverse weather conditions.
- Property portfolio maintained value over $2.3 billion.
- Positive outlook for FY26 with anticipated EBITDA growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$348 |
Annual Results Presentation
|
25 Aug 2025 9:15AM |
$0.685 |
$0.645 |
fallen by
5.84%
|
|
| Lakes Blue Energy NL (LKO) ORDINARY FULLY PAID |
Energy |
$24 |
Wombat-5 Well, Gippsland Basin, Victoria, Drilling Resumed
|
25 Aug 2025 9:14AM |
$0.905 |
$0.285 |
fallen by
68.51%
|
|
LKO - Price-sensitive ASX Announcement
Full Release
Key Points
- Lakes Blue Energy NL resumed drilling at the Wombat-5 Well in the Gippsland Basin, Victoria.
- Drilling recommencement followed the resolution of access, logistical, and technical delays.
- Operations are progressing according to plan and in compliance with regulatory and environmental standards.
- The primary objective is to evaluate the gas potential of the Strzelecki Group formations.
- Company reaffirmed commitment to exploration program and stakeholder engagement.
- Assurances provided regarding ongoing safety and environmental compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$348 |
Annual Results Announcement
|
25 Aug 2025 9:14AM |
$0.685 |
$0.645 |
fallen by
5.84%
|
|
| GDI Property Group (GDI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$348 |
Appendix 4E and Annual Financial Report
|
25 Aug 2025 9:13AM |
$0.685 |
$0.645 |
fallen by
5.84%
|
|
| Genetic Signatures Limited (GSS) ORDINARY FULLY PAID |
Health Care |
$13 |
FY25 Appendix 4E and Annual Report
|
25 Aug 2025 9:13AM |
$0.295 |
$0.058 |
fallen by
80.34%
|
|
GSS - Price-sensitive ASX Announcement
Full Release
Key Points
- Genetic Signatures Limited released its FY25 Appendix 4E and Annual Report for the year ended 30 June 2024.
- Total revenue for the period was reported at $16.8 million, showing a decrease compared to the previous financial year.
- The company recorded a net loss after tax of $10.0 million, reflecting continued investment in R&D and commercial activities.
- Significant investment in research and development, with $6.2 million spent during the year.
- Expansion of product range, including the launch of new EasyScreenâ„¢ kits targeting gastrointestinal and respiratory pathogens.
- Ongoing efforts to achieve regulatory approvals, including progress towards FDA submission for EasyScreenâ„¢ assays in the US market.
- Strengthening of commercial partnerships and distribution channels in both domestic and international markets.
- Corporate governance practices and board composition reviewed and updated to support strategic objectives.
- Remuneration policies detailed for directors and senior executives, with emphasis on performance-based incentives.
- The company remains focused on innovation, regulatory milestones, and market expansion to drive future growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Livium Ltd (LIT) ORDINARY FULLY PAID |
Industrials |
$17 |
A$6.6m Net Asset uplift
|
25 Aug 2025 9:13AM |
$0.011 |
$0.008 |
fallen by
27.27%
|
|
LIT - Price-sensitive ASX Announcement
Full Release
Key Points
- LIT (Livium Ltd) reports a net asset uplift of A$6.6 million.
- The uplift results from an independent revaluation of Livium Pty Ltd, a key investment.
- Livium Pty Ltd operates in legal technology and funding.
- The revaluation strengthens LIT’s net asset position.
- The Board welcomes the uplift as recognition of Livium’s business model and future potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.